1
2
Geenen, Joost W., Boersmaz, Cornelis, Klungel, Olaf H., Hovels, Anke M.
Veröffentlicht in: Geenen , J W , Boersmaz , C , Klungel , O H & Hovels , A M 2019 , ' Accuracy of budget impact estimations and impact on patient access : a hepatitis C case study ' , European Journal of Health Economics , vol. 20 , no. 6 , pp. 857-867 . https://doi.org/10.1007/s10198-019-01048-z;
2019
Veröffentlicht in: Geenen , J W , Boersmaz , C , Klungel , O H & Hovels , A M 2019 , ' Accuracy of budget impact estimations and impact on patient access : a hepatitis C case study ' , European Journal of Health Economics , vol. 20 , no. 6 , pp. 857-867 . https://doi.org/10.1007/s10198-019-01048-z;
2019
3
4
5
6
7
Geenen, Joost W., Belitser, Svetlana, Vreman, Rick A., van Bloois, Martijn, Klungel, Olaf H., Boersma, Cornelis, Hovels, Anke M.
Veröffentlicht in: Geenen , J W , Belitser , S , Vreman , R A , van Bloois , M , Klungel , O H , Boersma , C & Hovels , A M 2020 , ' A novel method for predicting the budget impact of innovative medicines : validation study for oncolytics ' , European Journal of Health Economics , vol. 21 , no. 6 , pp. 845-853 . https://doi.org/10.1007/s10198-020-01176-x;
2020
Veröffentlicht in: Geenen , J W , Belitser , S , Vreman , R A , van Bloois , M , Klungel , O H , Boersma , C & Hovels , A M 2020 , ' A novel method for predicting the budget impact of innovative medicines : validation study for oncolytics ' , European Journal of Health Economics , vol. 21 , no. 6 , pp. 845-853 . https://doi.org/10.1007/s10198-020-01176-x;
2020
8
9
10